RxDoctor Payments Data

Charles Sawyers

Hematology & Oncology · New York, NYNPI 1063432052

Payments from drug & device makers

What this record shows

This record is dominated by other: $1,266,522 of the $1,553,249 with a category attached, or 81.5%. Sanofi accounts for 81.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,307,357, more than ten times the $16,000 reported in 2019. Among hematology & oncology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,553,249in general payments, 2019–2025

Across 60 payments — averaging $25,887 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1.3M
  • Blueprint Medicines Corporation$116K
  • Beigene, Ltd.$100K
  • Agios Pharmaceuticals, Inc.$36K
  • Novartis$14K
  • Beone Medicines USA, Inc.$12K
  • plus $4K from 2 others

What the payments were for

  • Consulting fees$285,83518%
  • Travel & lodging$8910%
  • Other$1,266,52282%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,553,249 in reported general payments places this provider in the 95th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Other hematology & oncology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →